Progress of drug therapy for gout and hyperuricemia
Nie Yin
Abstract
Nie Yin
Abstract
Currently,primary gout still cannot be cured,for which the blood uric acid is controlled to be less than 360μmol/L mainly by drug therapy while for patients with gouty tophus the blood uric acid is controlled to be less than238 μmol /L. So far,frequently-used drugs are mainly colchicines that treating acute gout by acting on neutrophile granulocyte,selective and non-selective cyclooxygenase inhibitor-nonsteroidal anti-inflammatory drugs( NAIDS),glucocorticoids and xanthine oxidase( XO) inhibitor-allopurinol,etc.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Currently,primary gout still cannot be cured,for which the blood uric acid is controlled to be less than 360μmol/L mainly by drug therapy while for patients with gouty tophus the blood uric acid is controlled to be less than238 μmol /L. So far,frequently-used drugs are mainly colchicines that treating acute gout by acting on neutrophile granulocyte,selective and non-selective cyclooxygenase inhibitor-nonsteroidal anti-inflammatory drugs( NAIDS),glucocorticoids and xanthine oxidase( XO) inhibitor-allopurinol,etc.
Key concepts: Medicine, Gout, Allopurinol, Hyperuricemia, Febuxostat, Uric acid, Xanthine oxidase inhibitor, Tophus